Trial Outcomes & Findings for Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair (NCT NCT01756560)
NCT ID: NCT01756560
Last Updated: 2019-05-14
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE4
Target enrollment
2 participants
Primary outcome timeframe
72 hours
Results posted on
2019-05-14
Participant Flow
Participant milestones
| Measure |
Control
in this group, plain bupivacaine will be used to block femoral and sciatic nerve
Bupivacaine
|
Dexamethasone
Bupivacaine mixed with dexamethasone will be used to block femoral and sciatic nerve
dexamethsone
Bupivacaine
|
|---|---|---|
|
Overall Study
STARTED
|
2
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair
Baseline characteristics by cohort
| Measure |
Control
n=2 Participants
in this group, plain bupivacaine will be used to block femoral and sciatic nerve
Bupivacaine
|
Dexamethasone
Bupivacaine mixed with dexamethasone will be used to block femoral and sciatic nerve
dexamethsone
Bupivacaine
|
Total
n=2 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
—
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
2 Participants
n=5 Participants
|
—
|
2 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
—
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
—
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
—
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
2 participants
n=5 Participants
|
—
|
2 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 72 hoursPopulation: study terminated early due to lack of resources to recruit subjects and no data was collected for Outcome measures
Outcome measures
Outcome data not reported
Adverse Events
Control
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Dexamethasone
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place